Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Synergistic Anti-tumor Effect of ChangTai Keli Based on Chemotherapy for Colon Cancer Patients：a Randomized, Parallel-group, Double-blind, Multicenter Clinical Study

NCT02510118 is registered in ClinicalTrials.gov with Nanjing NingQi Medicine Science and Technology Co., Ltd. as lead sponsor.

NCT NCT02510118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02510118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Synergistic Anti-tumor Effect of ChangTai Keli Based on Chemotherapy for Colon Cancer Patients：a Randomized, Parallel-group, Double-blind, Multicenter Clinical Study
Lead sponsor
Nanjing NingQi Medicine Science and Technology Co., Ltd.
Phase
Phase 2/3
Overall status
Unknown status
Start date
June 30, 2015
Completion date
June 30, 2018
Enrollment
360 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer